210 related articles for article (PubMed ID: 21704931)
1. Intracranial venous sinus stenting for benign intracranial hypertension: clinical indications, technique, and preliminary results.
Albuquerque FC; Dashti SR; Hu YC; Newman CB; Teleb M; McDougall CG; Rekate HL
World Neurosurg; 2011; 75(5-6):648-52; discussion 592-5. PubMed ID: 21704931
[TBL] [Abstract][Full Text] [Related]
2. Utility of CT venography in monitoring stent patency in idiopathic intracranial hypertension: retrospective single-center study.
Shlapak DP; Lanzino G; Morris PP; Theiler AR; Brinjikji W
J Neurointerv Surg; 2021 May; 13(5):478-482. PubMed ID: 32769112
[TBL] [Abstract][Full Text] [Related]
3. Endovascular treatment of idiopathic intracranial hypertension: clinical and radiologic outcome of 10 consecutive patients.
Donnet A; Metellus P; Levrier O; Mekkaoui C; Fuentes S; Dufour H; Conrath J; Grisoli F
Neurology; 2008 Feb; 70(8):641-7. PubMed ID: 18285539
[TBL] [Abstract][Full Text] [Related]
4. Venous sinus stenting for idiopathic intracranial hypertension: a review of the literature.
Puffer RC; Mustafa W; Lanzino G
J Neurointerv Surg; 2013 Sep; 5(5):483-6. PubMed ID: 22863980
[TBL] [Abstract][Full Text] [Related]
5. Transverse venous sinus stent placement as treatment for benign intracranial hypertension in a young male: case report and review of the literature.
Rajpal S; Niemann DB; Turk AS
J Neurosurg; 2005 Apr; 102(3 Suppl):342-6. PubMed ID: 15881764
[TBL] [Abstract][Full Text] [Related]
6. Patency of the vein of Labbé after venous stenting of the transverse and sigmoid sinuses.
Raper DMS; Ding D; Chen CJ; Buell TJ; Crowley RW; Liu KC
J Neurointerv Surg; 2017 Jun; 9(6):587-590. PubMed ID: 28073989
[TBL] [Abstract][Full Text] [Related]
7. Dural sinus stent placement for idiopathic intracranial hypertension.
Kumpe DA; Bennett JL; Seinfeld J; Pelak VS; Chawla A; Tierney M
J Neurosurg; 2012 Mar; 116(3):538-48. PubMed ID: 22149379
[TBL] [Abstract][Full Text] [Related]
8. Long-term patency of venous sinus stents for idiopathic intracranial hypertension.
Ducruet AF; Crowley RW; McDougall CG; Albuquerque FC
J Neurointerv Surg; 2014 Apr; 6(3):238-42. PubMed ID: 23585640
[TBL] [Abstract][Full Text] [Related]
9. Dural venous sinus stenting for treatment of pediatric idiopathic intracranial hypertension.
Lee KE; Zehri A; Soldozy S; Syed H; Catapano JS; Maurer R; Albuquerque FC; Liu KC; Wolfe SQ; Brown S; Levitt MR; Fargen KM
J Neurointerv Surg; 2021 May; 13(5):465-470. PubMed ID: 32732257
[TBL] [Abstract][Full Text] [Related]
10. Transverse venous stenting for the treatment of idiopathic intracranial hypertension, or pseudotumor cerebri.
Cappuzzo JM; Hess RM; Morrison JF; Davies JM; Snyder KV; Levy EI; Siddiqui AH
Neurosurg Focus; 2018 Jul; 45(1):E11. PubMed ID: 29961386
[TBL] [Abstract][Full Text] [Related]
11. Intracranial venous pressures under conscious sedation and general anesthesia.
Raper DMS; Buell TJ; Chen CJ; Ding D; Starke RM; Liu KC
J Neurointerv Surg; 2017 Oct; 9(10):986-989. PubMed ID: 28360352
[TBL] [Abstract][Full Text] [Related]
12. Visual and neurological outcomes following endovascular stenting for pseudotumor cerebri associated with transverse sinus stenosis.
Radvany MG; Solomon D; Nijjar S; Subramanian PS; Miller NR; Rigamonti D; Blitz A; Gailloud P; Moghekar A
J Neuroophthalmol; 2013 Jun; 33(2):117-22. PubMed ID: 23502837
[TBL] [Abstract][Full Text] [Related]
13. Development of an Intracranial Dural Arteriovenous Fistula after Venous Sinus Stenting for Idiopathic Intracranial Hypertension.
Buell TJ; Raper DM; Ding D; Chen CJ; Liu KC
J Neurointerv Surg; 2018 Jul; 10(7):e15. PubMed ID: 29563208
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for failed transverse sinus stenting in pseudotumor cerebri patients.
Goodwin CR; Elder BD; Ward A; Orkoulas-Razis D; Kosztowski TA; Hoffberger J; Moghekar A; Radvany M; Rigamonti D
Clin Neurol Neurosurg; 2014 Dec; 127():75-8. PubMed ID: 25459247
[TBL] [Abstract][Full Text] [Related]
15. Impaired drainage of vein of Labbé following venous sinus stenting for idiopathic intracranial hypertension.
Boddu SR; Gobin YP; Dinkin M; Oliveira C; Patsalides A
J Neurointerv Surg; 2019 Mar; 11(3):300-306. PubMed ID: 30219791
[TBL] [Abstract][Full Text] [Related]
16. Effect of Body Mass Index on Venous Sinus Pressures in Idiopathic Intracranial Hypertension Patients Before and After Endovascular Stenting.
Raper DMS; Ding D; Buell TJ; Crowley RW; Starke RM; Liu KC
Neurosurgery; 2018 Apr; 82(4):555-561. PubMed ID: 28431144
[TBL] [Abstract][Full Text] [Related]
17. Quality of life, need for retreatment, and the re-equilibration phenomenon after venous sinus stenting for idiopathic intracranial hypertension.
Garner RM; Aldridge JB; Wolfe SQ; Fargen KM
J Neurointerv Surg; 2021 Jan; 13(1):79-85. PubMed ID: 32611623
[TBL] [Abstract][Full Text] [Related]
18. Predicting the need for retreatment in venous sinus stenting for idiopathic intracranial hypertension.
Kahan J; Sundararajan S; Brown K; Dinkin M; Oliveira C; Patsalides A
J Neurointerv Surg; 2021 Jun; 13(6):574-579. PubMed ID: 32895320
[TBL] [Abstract][Full Text] [Related]
19. Reductions in bilateral transverse sinus pressure gradients with unilateral transverse venous sinus stenting for idiopathic intracranial hypertension.
Larson A; Rinaldo L; Chen JJ; Cutsforth-Gregory J; Theiler AR; Brinjikji W
J Neurointerv Surg; 2021 Feb; 13(2):187-190. PubMed ID: 32482835
[TBL] [Abstract][Full Text] [Related]
20. A case series of dural venous sinus stenting in idiopathic intracranial hypertension: association of outcomes with optical coherence tomography.
Smith KA; Peterson JC; Arnold PM; Camarata PJ; Whittaker TJ; Abraham MG
Int J Neurosci; 2017 Feb; 127(2):145-153. PubMed ID: 26863329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
